Invesco Ltd. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 1 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$9,567
+37.2%
76,721
+13.3%
0.00%
Q4 2022$6,974
-30.3%
67,7100.0%0.00%
Q3 2022$10,000
-83.1%
67,710
+0.6%
0.00%
Q2 2022$59,000
-27.2%
67,313
+2.5%
0.00%
Q1 2022$81,000
-36.2%
65,657
+1.1%
0.00%
Q4 2021$127,000
-58.9%
64,946
-42.5%
0.00%
Q3 2021$309,000
+14.4%
113,013
+32.1%
0.00%
Q2 2021$270,00085,5710.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 20,000$14,0000.02%
Hartford Financial Management Inc. 16,000$11,0000.00%
RBF Capital, LLC 25,000$19,0000.00%
Koshinski Asset Management, Inc. 20,000$14,0000.00%
Financial Advocates Investment Management 23,097$16,0000.00%
D.A. DAVIDSON & CO. 110,000$76,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 162,714$112,0000.00%
HighTower Advisors, LLC 132,328$91,0000.00%
Virtu Financial LLC 15,854$11,0000.00%
BlackRock Inc. 31,631$22,0000.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders